OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
Francesco Di Costanzo, Federica Di Costanzo, Lorenzo Antonuzzo, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 416-416
Open Access | Times Cited: 23
Francesco Di Costanzo, Federica Di Costanzo, Lorenzo Antonuzzo, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 416-416
Open Access | Times Cited: 23
Showing 23 citing articles:
Toyaburgine, a Synthetic N-Biphenyl-Dihydroisoquinoline Inspired by Related N,C-Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models
Suresh Awale, Juthamart Maneenet, Nguyễn Duy Phan, et al.
ACS Chemical Biology (2025)
Closed Access
Suresh Awale, Juthamart Maneenet, Nguyễn Duy Phan, et al.
ACS Chemical Biology (2025)
Closed Access
Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis
Jiaqiang Ren, Tong Su, Jiachun Ding, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Jiaqiang Ren, Tong Su, Jiachun Ding, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine
Rohit Sharma, Sourabh Kumar, Kumari Komal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Rohit Sharma, Sourabh Kumar, Kumari Komal, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Registry Study
Robert C.G. Martin, Rebekah R. White, Malcolm M. Bilimoria, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3894-3894
Open Access | Times Cited: 3
Robert C.G. Martin, Rebekah R. White, Malcolm M. Bilimoria, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3894-3894
Open Access | Times Cited: 3
Brusatol alleviates pancreatic carcinogenesis via targeting NLRP3 in transgenic Krastm4Tyj Trp53tm1Brn Tg (Pdx1-cre/Esr1*) #Dam mice
Juan Zhang, Yulin Wu, Hong‐Xi Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116977-116977
Open Access | Times Cited: 2
Juan Zhang, Yulin Wu, Hong‐Xi Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116977-116977
Open Access | Times Cited: 2
Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis
Guojun Yan, Kai Zhang, Lijun Yan, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Guojun Yan, Kai Zhang, Lijun Yan, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends
Rana Muhammad Anss Bin Qadir, Musab bin Umair, Umar Bin Tariq, et al.
Cureus (2024)
Open Access | Times Cited: 2
Rana Muhammad Anss Bin Qadir, Musab bin Umair, Umar Bin Tariq, et al.
Cureus (2024)
Open Access | Times Cited: 2
Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma
Huey‐Jen Lin, Yingguang Liu, Kailey Caroland, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3507-3507
Open Access | Times Cited: 6
Huey‐Jen Lin, Yingguang Liu, Kailey Caroland, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3507-3507
Open Access | Times Cited: 6
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells
Vinod Ganju, Gavin Marx, Scott Pattison, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 2, pp. 304-314
Closed Access | Times Cited: 4
Vinod Ganju, Gavin Marx, Scott Pattison, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 2, pp. 304-314
Closed Access | Times Cited: 4
Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Jianjun Gao, Jiangang Wang, Canghai Guan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2214-2228
Open Access | Times Cited: 1
Jianjun Gao, Jiangang Wang, Canghai Guan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 8, pp. 2214-2228
Open Access | Times Cited: 1
TGFB2 mRNA Levels Prognostically Interact with Interferon-Alpha Receptor Activation of IRF9 and IFI27, and an Immune Checkpoint LGALS9 to Impact Overall Survival in Pancreatic Ductal Adenocarcinoma
Sanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11221-11221
Open Access | Times Cited: 1
Sanjive Qazi, Vuong Trieu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11221-11221
Open Access | Times Cited: 1
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Yohei Saito, Yi Xiao, Jun Yao, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Yohei Saito, Yi Xiao, Jun Yao, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Gold nanoparticles decorated FOLFIRINOX loaded liposomes for synergistic therapy of pancreatic cancer
Emine Yılmaz, Demet Kaçaroğlu, Ayse Kevser Ozden, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125067-125067
Closed Access | Times Cited: 1
Emine Yılmaz, Demet Kaçaroğlu, Ayse Kevser Ozden, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125067-125067
Closed Access | Times Cited: 1
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote, et al.
Cell Reports Medicine (2024), pp. 101881-101881
Open Access | Times Cited: 1
Ganji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B. Foote, et al.
Cell Reports Medicine (2024), pp. 101881-101881
Open Access | Times Cited: 1
Verteporfin fluorescence in antineoplastic-treated pancreatic cancer cells found concentrated in mitochondria
Ying-Qiao Zhang, Qinghao Liu, Lu Liu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 968-978
Open Access
Ying-Qiao Zhang, Qinghao Liu, Lu Liu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 968-978
Open Access
The prognostic impact of surufatinib for the treatment of advanced pancreatic ductal adenocarcinoma: A single center retrospective study
Yanzhen Yang, Qu Xie, Lai Jiang, et al.
Research Square (Research Square) (2024)
Open Access
Yanzhen Yang, Qu Xie, Lai Jiang, et al.
Research Square (Research Square) (2024)
Open Access
Nimbolide: A Potential Phytochemical Agent in Multimodal Pancreatic Cancer Therapies
Mukesh K. Jogi, Hitakshi Asnani, Sohini Singh, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 27-41
Closed Access
Mukesh K. Jogi, Hitakshi Asnani, Sohini Singh, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 27-41
Closed Access
Efficacy and Safety of Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy in Patients with Pancreatic Cancer Peritoneal Metastasis
Guojun Yan, Kai Zhang, Lijun Yan, et al.
Research Square (Research Square) (2024)
Open Access
Guojun Yan, Kai Zhang, Lijun Yan, et al.
Research Square (Research Square) (2024)
Open Access
Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression—A Scoping Review
Elena Orlandi, Massimo Guasconi, Stefano Vecchia, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2912-2912
Open Access
Elena Orlandi, Massimo Guasconi, Stefano Vecchia, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2912-2912
Open Access
Pancreatic Cancer- Secreted Proteins: Targeting Their Functions in Tumor Microenvironment
Anna Lisa Cammarota, Antonia Falco, Anna Basile, et al.
(2023)
Open Access | Times Cited: 1
Anna Lisa Cammarota, Antonia Falco, Anna Basile, et al.
(2023)
Open Access | Times Cited: 1
Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment
Anna Lisa Cammarota, Antonia Falco, Anna Basile, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4825-4825
Open Access | Times Cited: 1
Anna Lisa Cammarota, Antonia Falco, Anna Basile, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4825-4825
Open Access | Times Cited: 1
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients
Daniele Lavacchi, S. Polvani, Antonio Taddei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Daniele Lavacchi, S. Polvani, Antonio Taddei, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
A Case of Complete Remission from Pancreatic Cancer Following Palliative Chemotherapy
J. Lee, Han Taek Jeong, June Hwa Bae
The Korean Journal of Pancreas and Biliary Tract (2023) Vol. 28, Iss. 4, pp. 131-136
Open Access
J. Lee, Han Taek Jeong, June Hwa Bae
The Korean Journal of Pancreas and Biliary Tract (2023) Vol. 28, Iss. 4, pp. 131-136
Open Access
